As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.

Translate

French German Italian Portuguese Russian

Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders

Clinical Trial Title: 
Public health surveillance for the prevention of complications of bleeding and clotting disorders.
Clinical Trial Protocol ID: 
14041605
Clinical Trial Investigator Name: 
Lisa Boggio, MD
Clinical Trial Protocol Description: 

HIV and hepatitis C screening. Lab draws for testing inhibitors.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have hemophilia, von Willebrand disease, or another bleeding disorder.
  • Have received blood based product via infusion/transfusion.

This is a partial list of elgibility requirements.

Clinical Trial Area: 
Blood Disorders and Hematologic Cancers
Contact Phone: 
(312) 942-3034
Contact Name: 
Lisa Boggio, MD